Abstract
META-ANALYSIS: A meta-analysis of published randomized control trials of nifedipine in hypertension and stable angina pectoris was performed.
Results:
The results suggest a formulation-dependent increased risk of mortality and adverse cardiovascular outcomes for monotherapy use in patients with stable angina pectoris. No increased risk was seen in the hypertension studies.
Publication types
-
Meta-Analysis
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Humans
-
Hypertension / drug therapy*
-
Hypertension / mortality
-
Hypertension / physiopathology
-
Myocardial Ischemia / drug therapy*
-
Myocardial Ischemia / mortality
-
Myocardial Ischemia / physiopathology
-
Nifedipine / therapeutic use*
-
Randomized Controlled Trials as Topic*
-
Vasodilator Agents / therapeutic use*
Substances
-
Vasodilator Agents
-
Nifedipine